F.L. Putnam Investment Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $19.3M | Buy |
138,526
+32,786
| +31% | +$4.59M | 0.29% | 68 |
|
|
2025
Q4 | $13M | Buy |
105,740
+42,243
| +67% | +$5.13M | 0.19% | 97 |
|
|
2025
Q3 | $7.05M | Buy |
63,497
+3,395
| +6% | +$386K | 0.11% | 145 |
|
|
2025
Q2 | $6.66M | Buy |
60,102
+29,731
| +98% | +$3.16M | 0.11% | 144 |
|
|
2025
Q1 | $3.4M | Buy |
30,371
+24,599
| +426% | +$2.54M | 0.06% | 184 |
|
|
2024
Q4 | $533K | Buy |
5,772
+490
| +9% | +$44.1K | 0.01% | 408 |
|
|
2024
Q3 | $443K | Buy |
5,282
+2
| +0% | +$153 | 0.01% | 444 |
|
|
2024
Q2 | $362K | Buy |
5,280
+2,206
| +72% | +$147K | 0.01% | 462 |
|
|
2024
Q1 | $225K | Sell |
3,074
-2,996
| -49% | -$230K | ﹤0.01% | 452 |
|
|
2023
Q4 | $492K | Buy |
6,070
+826
| +16% | +$64.3K | 0.01% | 337 |
|
|
2023
Q3 | $393K | Buy |
5,244
+1,671
| +47% | +$129K | 0.01% | 370 |
|
|
2023
Q2 | $275K | Buy |
3,573
+422
| +13% | +$33.7K | 0.01% | 417 |
|
|
2023
Q1 | $261K | Buy |
3,151
+763
| +32% | +$63.2K | 0.01% | 376 |
|
|
2022
Q4 | $205K | Buy |
+2,388
| New | +$189K | 0.01% | 387 |
|
|
2021
Q2 | – | Sell |
-4,806
| Closed | -$311K | – | 408 |
|
|
2021
Q1 | $311K | Sell |
4,806
-4,512
| -48% | -$291K | 0.01% | 296 |
|
|
2020
Q4 | $543K | Sell |
9,318
-62
| -0.7% | -$3.74K | 0.03% | 219 |
|
|
2020
Q3 | $593K | Sell |
9,380
-1,325
| -12% | -$91.9K | 0.03% | 196 |
|
|
2020
Q2 | $824K | Buy |
10,705
+2,167
| +25% | +$166K | 0.05% | 162 |
|
|
2020
Q1 | $638K | Sell |
8,538
-1,415
| -14% | -$97.8K | 0.05% | 168 |
|
|
2019
Q4 | $647K | Buy |
9,953
+1,732
| +21% | +$113K | 0.04% | 205 |
|
|
2019
Q3 | $521K | Buy |
8,221
+2,096
| +34% | +$137K | 0.04% | 195 |
|
|
2019
Q2 | $414K | Buy |
6,125
+346
| +6% | +$22.8K | 0.03% | 168 |
|
|
2019
Q1 | $376K | Buy |
5,779
+186
| +3% | +$12.4K | 0.03% | 170 |
|
|
2018
Q4 | $350K | Buy |
5,593
+802
| +17% | +$56.1K | 0.04% | 169 |
|
|
2018
Q3 | $370K | Buy |
4,791
+216
| +5% | +$16.3K | 0.03% | 173 |
|
|
2018
Q2 | $324K | Sell |
4,575
-3,733
| -45% | -$264K | 0.03% | 179 |
|
|
2018
Q1 | $626K | Sell |
8,308
-11,903
| -59% | -$946K | 0.06% | 164 |
|
|
2017
Q4 | $1.45M | Sell |
20,211
-2,205
| -10% | -$167K | 0.13% | 130 |
|
|
2017
Q3 | $1.82M | Buy |
+22,416
| New | +$1.71M | 0.17% | 109 |
|
|
2017
Q1 | $4.79M | Sell |
70,598
-23,372
| -25% | -$1.64M | 0.5% | 66 |
|
|
2016
Q4 | $6.73M | Sell |
93,970
-6,186
| -6% | -$460K | 0.77% | 43 |
|
|
2016
Q3 | $7.92M | Sell |
100,156
-64,391
| -39% | -$5.23M | 0.9% | 40 |
|
|
2016
Q2 | $13.7M | Sell |
164,547
-24,832
| -13% | -$2.2M | 1.63% | 23 |
|
|
2016
Q1 | $17.4M | Sell |
189,379
-9,172
| -5% | -$827K | 2.08% | 9 |
|
|
2015
Q4 | $20.1M | Sell |
198,551
-8,770
| -4% | -$913K | 2.35% | 7 |
|
|
2015
Q3 | $20.4M | Buy |
207,321
+53
| +0% | +$5.89K | 2.52% | 4 |
|
|
2015
Q2 | $24.3M | Sell |
207,268
-2,140
| -1% | -$234K | 2.7% | 4 |
|
|
2015
Q1 | $20.5M | Sell |
209,408
-6,894
| -3% | -$700K | 2.29% | 7 |
|
|
2014
Q4 | $20.4M | Buy |
216,302
+23,471
| +12% | +$2.43M | 2.37% | 8 |
|
|
2014
Q3 | $20.5M | Sell |
192,831
-2,765
| -1% | -$271K | 2.41% | 5 |
|
|
2014
Q2 | $16.2M | Sell |
195,596
-7,158
| -4% | -$557K | 1.87% | 10 |
|
|
2014
Q1 | $14.4M | Sell |
202,754
-66,915
| -25% | -$5.25M | 1.71% | 13 |
|
|
2013
Q4 | $20.3M | Sell |
269,669
-31,380
| -10% | -$2.19M | 2.44% | 5 |
|
|
2013
Q3 | $18.9M | Sell |
301,049
-1,590
| -0.5% | -$95K | 2.52% | 1 |
|
|
2013
Q2 | $15.5M | Buy |
+302,639
| New | +$15.8M | 2.22% | 4 |
|
Other funds holding GILD
VCM
VPM
F.L. Putnam Investment Management's GILD Position: Q1 2026 in Review
F.L. Putnam Investment Management increased its Gilead Sciences (GILD) stake by 31% in Q1 2026, buying an estimated $4.59M and bringing the position to 138,526 shares worth $19.3M. The position accounts for 0.29% of the portfolio, ranked #68.
F.L. Putnam Investment Management first reported a position in GILD in Q2 2013 and has held it in 45 quarters since. The position peaked at $24.3M in Q2 2015. 2,311 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- F.L. Putnam Investment Management held 138,526 shares of Gilead Sciences worth $19.3M as of Q1 2026.
- F.L. Putnam Investment Management bought 32,786 Gilead Sciences shares in Q1 2026, an estimated $4.59M.
- Gilead Sciences made up 0.29% of F.L. Putnam Investment Management's portfolio in Q1 2026, its #68 holding.
- F.L. Putnam Investment Management first reported a position in Gilead Sciences in Q2 2013 and has held it in 45 quarters since.
- F.L. Putnam Investment Management's Gilead Sciences position peaked at $24.3M in Q2 2015.
- 2,311 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on F.L. Putnam Investment Management's 13F filing for Q1 2026, filed 5 May 2026.